Tracking guide

How to Tell If Your Hair Loss Treatment Is Actually Working

Trials count success in hairs per square centimeter and blinded photo ratings. Learn what those endpoints mean, what your own photos can honestly show, and when to accept that a treatment is not delivering.

Short answer

A hair loss treatment is working if, over 6 to 12 months, standardized photos show less visible scalp in the same spot, a narrower part, or slowed progression. Trials define success as measurable gains in hair density or thickness, and those gains are usually too small to notice week to week. Stabilization, meaning hair loss that stops advancing, also counts as success. Judge with repeatable photos at fixed intervals, not daily mirror checks or how your hair feels that day.

October 26, 20261,007 words9 sourcesUpdated Oct 26, 2026

A hair loss treatment is working if, over 6 to 12 months, your standardized photos show less visible scalp in the same spot, a narrower part line, or hair loss that has simply stopped advancing. Clinical trials never judge success by how a participant feels. They count hairs per square centimeter, measure shaft thickness, and have blinded reviewers rate standardized photographs. Those same principles translate directly to what you can do at home, and they protect you from both false hope and false despair.

The gains that count as success in trials are modest, and that is the uncomfortable part. A device trial considered a between-group difference of about 24 hairs per square centimeter at six months a significant win [3]. An exosome delivery study reported a mean increase of about 17 hairs per square centimeter at week 12 [9]. Changes of that size are real, but they are invisible in a casual mirror glance. They only become visible when you compare disciplined photos taken months apart under identical conditions.

What trials measureWhat it actually tells youWhat you can do at home
Hair density (hairs/cm²)Whether more hairs are growing in a defined patch of scalpNot countable by eye, but visible indirectly as less scalp showing through
Hair shaft diameter and cumulative thicknessWhether existing hairs are getting thicker, which fills in coverageVisible only as a subtle change in how dense hair looks in photos
Standardized global photographyWhether blinded reviewers see improvement at fixed angles and lightingDirectly reproducible with a fixed photo protocol
Part widthWhether the part line is narrowing or widening over timeOne of the most reliable home signals, if the photo angle is fixed
Pull test and shedding countsWhether active shedding is slowingTrackable in rough terms, with big day-to-day noise

What counts as success in a clinical trial

When researchers test a hair loss treatment, they pick endpoints before the study starts. Common ones include target-area hair count measured in hairs per square centimeter, hair shaft diameter, terminal hair density, and blinded ratings of standardized photographs [2] [3]. A six-month trial of a wearable device, for example, assessed participants at baseline, month 3, and month 6 using standardized global photography and trichoscopic analysis [3]. That assessment schedule is a good model for your own check-ins.

Different treatments produce different signatures of improvement. In a review of minoxidil combined with PRP, topical 5% minoxidil produced steady gains in hair shaft thickness over extended follow-up, while monthly PRP injections converted hair pull tests more quickly, by week 12 [1]. A pilot trial of topical latanoprost acid measured its primary endpoint as within-participant change in target-area hair count over six months, and also tracked trichoscopic markers like yellow dots and follicular-unit remodeling [2]. The pattern matters for your expectations. Some treatments thicken existing hairs first, some reduce shedding first, and some add visible density later.

Notice what is absent from that list. No trial treats daily mirror impressions or shower-drain counts as evidence. Patient satisfaction appears only as a secondary outcome, and it can point in a different direction than the measurements. In one trial, patients adding topical cetirizine to minoxidil reported higher satisfaction despite no objective difference in hair density, diameter, or photo scores [8].

What your own photos can honestly show

A home photo protocol works only if it removes every variable except your hair. Same camera or phone, same distance, same angle, same lighting, and the same wet-or-dry state each time. Comb your part in the same place, or photograph a fixed landmark like a mole or cowlick so you can line up shots later. Take photos at month 0, 3, 6, and 12, and compare only against the baseline, never against yesterday.

Part width is the most forgiving home signal because it changes slowly and photographs clearly from a fixed overhead angle. Density shifts of 15 to 25 hairs per square centimeter, the range trials treat as meaningful [3] [9], will not register up close. Over six months of consistent shots, they show up as slightly less scalp visible through the hair. Shedding counts are the weakest signal. They swing widely from day to day, so a bad week means almost nothing on its own.

Why progress can look different depending on the treatment

Your timeline expectations should match how the treatment works. Minoxidil tends to thicken existing shafts gradually, so judge it on thickness and coverage at month 6 and beyond [1]. PRP acts faster on shedding, with pull test changes by week 12 in trials, but results vary between clinics because preparation methods, spin protocols, and injected volumes differ widely [1] [7]. If you are paying for PRP, ask which protocol your clinic uses and hold it to the same photo standard as anything else.

Be more skeptical of add-ons. Topical tretinoin paired with minoxidil has minimal clinical combination data, and one randomized trial found similar outcomes between the pair and minoxidil alone [4]. That does not mean adjuncts never help, but it means the burden of proof sits with your photos. An adjunct earns its place only if your fixed shots improve beyond what the base treatment delivered.

When to accept a treatment is not working

Give most treatments at least six months before judging, and twelve for a fair verdict. If your month-12 photos show a wider part or more scalp visible in the same spots, the treatment is probably not holding the line. If the photos look identical to baseline, that may still be success, because untreated androgenetic alopecia usually keeps progressing. Stabilization is a real outcome, not a consolation prize.

When photos confirm continued loss, the next step is a conversation with a clinician about switching, combining, or investigating other causes. Scalp conditions can mimic or worsen pattern loss, and a professional examination or trichoscopy can catch what photos cannot. What you should not do is abandon a treatment at week 8 because the mirror looks unchanged, or keep spending on one that your own documented record contradicts.

Sources

01Efficacy and Safety of Platelet-Rich Plasma Versus Topical Minoxidil in Androgenetic Alopecia: A Systematic Review. · Cureus · 2026-08-26

02Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation. · Pharmacological reports : PR · 2026-07-10

03Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial. · Dermatology and therapy · 2026-04-22

04Efficacy of Topical Tretinoin and Topical Minoxidil Cotherapy in Androgenetic Alopecia: A Review. · Skin appendage disorders · 2026-06-18

05Evaluating the Effectiveness of Commercial Oral Supplements for Hair Growth: A Systematic Review and Meta-Analysis. · Journal of cosmetic dermatology · 2026-04-01

06Scalp Cooling as a Biopsychosocial Intervention in Patients Receiving Highly Alopecia-Inducing Chemotherapy: Prospective Single-Arm Study. · JMIR cancer · 2026-07-20

07Beyond conventional PRP: a rationale for bioengineered, growth-factor-defined platelet mimetics in alopecia-the precision re-engineered efficacy optimization framework. · Stem cell research & therapy · 2026-07-24

08Clinical Outcomes of Adding Topical Cetirizine to Minoxidil Therapy in Patients with Androgenetic Alopeci. · Journal of research in pharmacy practice · 2026-09-04

09Plasma and Sonophoresis-Assisted Topical Delivery of an Exosome for Androgenic Alopecia. · The Journal of craniofacial surgery · 2026-04-07

Common questions

How long should I wait before judging a hair loss treatment?

Use the trial schedule as your guide: assess at 3, 6, and 12 months, not weekly. Trials commonly run 12 weeks to 12 months, and many significant effects only became clear at the six-month mark [3] [5]. Judge before 3 months and you are mostly reading noise.

Is increased shedding in the first weeks a sign the treatment is failing?

No. Early shedding is a known phenomenon with growth-cycle-active treatments like minoxidil, as resting hairs are pushed out to make room for new growth. Judge the treatment on month 6 and month 12 photos, not on the shed count from the first several weeks.

Can I trust how my hair feels or how satisfied I am?

Only weakly. In one trial, patients adding topical cetirizine to minoxidil reported significantly higher satisfaction despite no objective difference in hair density, diameter, or photo scores [8]. A scalp cooling study similarly found objective hair retention had only a limited association with quality of life, while how patients appraised the experience mattered more [6]. Feelings are real, but they are not measurements.

Does stabilization count as working?

Yes. Androgenetic alopecia is progressive, so holding the line is a meaningful outcome. A treatment that stops further thinning is doing real work even if it produces no visible regrowth. Only fixed-angle photos taken months apart can tell you whether you are stable, improving, or still losing ground.